HomeCLTEF • OTCMKTS
add
Calliditas Therapeutics AB Share AK
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 559.78M | 107.80% |
Operating expense | 537.84M | 62.81% |
Net income | -47.48M | 48.36% |
Net profit margin | -8.48 | 75.15% |
Earnings per share | -0.17 | 90.21% |
EBITDA | -30.44M | 59.21% |
Effective tax rate | -11.29% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 797.28M | -7.95% |
Total assets | 1.75B | 2.23% |
Total liabilities | 1.64B | 36.16% |
Total equity | 106.79M | — |
Shares outstanding | 54.01M | — |
Price to book | — | — |
Return on assets | -4.58% | — |
Return on capital | -6.99% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -47.48M | 48.36% |
Cash from operations | -7.04M | 95.68% |
Cash from investing | -102.00K | 90.38% |
Cash from financing | -4.05M | -34.20% |
Net change in cash | -13.04M | 91.16% |
Free cash flow | -73.66M | 31.83% |
About
Founded
2004
Website
Employees
222
